Israeli Innovation Authority Investment in QART Medical

QART Medical is pleased to announce that we have been chosen by the Israeli Innovation Authority to receive an investment as part of their wartime aid package. We thank the Authority for their continued support and confidence.

.חברת QART Medical נבחרה ע”י רשות החדשנות לקבל השקעה לסיוע בעת מלחמה


About QART Medical

QART Medical is an ISO13485 certified MedTech company addressing the global infertility epidemic. To do so, QART has developed the Q300™, a breakthrough solution to male infertility issues that provides a quantitative characterization of sperm cell morphology to facilitate informed clinical decision making when selecting cells for use in in-vitro fertilization (IVF). QART aims to improve current success rates of Intra-Cytoplasmic Sperm Injection (ICSI) by quantitatively characterizing the morphology and composition of individual sperm cells with 3D topographic imaging. The Q300™ is registered with the US FDA, has received Israeli regulatory registration for commercial sales, and is in the process of CE-Mark registration.